7 March 2017

Pending Trades:

Limit Sell 142 shares of CORE @ $33.74 (0%)

Limit Sell 2773 shares of VSTM @ $1.20 (0%)

Limit Sell 530 shares of IPXL @ $9.50 (0%)

Purchases:

Purchased 169 shares of MDR @ $6.69

Sells:

N/A

Thoughts:

VSTM - Systematic investing. 5% and out. Target Price $2.50

**UPDATE** We've been in on VSTM since October 27th of 2016, so here's some commentary; VSTM is a clinical stage pharmaceutical and should catch some traction this year. Now...that could be tomorrow (fingers crossed) or that could be on December 31st. Regardless, if you look through the last three months, you'll see that the stock is very stable, which allows you to easily manipulate the purchase price and keeps you in play for a blow up day. For now, we are completely comfortable with this position and have no intention of giving up on it.  

MGNX - Systematic investing. 5% and out. Target Price $30.00

**UPDATE** Very similar to VSTM; MGNX is a clinical stage pharmaceutical that has found it's floor and should pick up serious traction sometime this year. While this stock fluctuates more than VSTM, it essentially floats between $19-$21...so there's some room to work around that price with buying low, selling high. We feel like VSTM is safer than MGNX, so if you have to pick one, pick VSTM. Could easily be trading @ $40 sometime this year.

CORE - Systematic investing. 5% and out.

AA - Systematic investing. 5% and out.

AUO - Systematic investing. 5% and out.

RES - Systematic investing. 5% and out.

ACET - Systematic investing. 5% and out.

IPXL - Pending trade.

HK - Systematic investing. 5% and out.

RRC - Systematic investing. 5% and out.

LONE - Systematic investing. 5% and out.

MDR - Systematic investing. 5% and out.

UA - We still really like the position of UA for a gain, but we felt like we could sell on this, purchase IPXL, and return to UA at a cheaper price than $19.03 which would be a double win...then IPXL drops 15%...tears.

CAB - We aren't in business of fighting with stocks or pride; we sold because CAB mostly likely isn't going to do anything positive for the next two months. If we can get a re-entry of 191 shares @ a price below $47.70, it's a win. Monitoring. First loss of the year.

USB - Sold @ $53.60. Need re-entry below to make it make sense. Target Price $70.00

CNAT - Monitoring for future.

DRYS - Beware of this stock. Monitoring for future.

SHOP - Sold @ $54.48. Need re-entry below to make it make sense. Target Price $65.00

NFX - Good position, monitoring.

 

James PauleyComment